Why this $7 billion ASX-listed company is a 'hidden gem': expert

This business supplies Chemist Warehouse, which is a giant that's still rapidly growing. And Australians still need pharmaceuticals regardless of inflation or wars.

| More on:
Contented looking man leans back in his chair at his desk and smiles.

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A little-known ASX stock that represents a supplier for the ubiquitous Chemist Warehouse chain is set to zoom ahead this year.

That's the opinion of Prime Value portfolio manager Shih Thin Wong, who said that in turbulent times such as now, businesses with resilient demand would win.

"I want to be comfortable owning companies which I think will give me earnings growth profile regardless of the macro environment," he told Switzer TV Investing

"And can control a number of elements that will drive growth internally… And I want to be owning companies that are less reliant on what's happening in the global financial markets."

We'll continue to buy regardless of economy

One ASX share that fits all those criteria is New Zealand's EBOS Group Ltd (ASX: EBO), according to Wong.

"It's not a company which is really followed by Australian fund managers that closely. But it's a hidden gem in the mid-cap space."

Wong notes that one of EBOS' clients is a huge retailer that all Australians will have shopped at one time or another. 

"It really is a key supplier to Chemist Warehouse, which we know is growing very strongly. So there's growth in that pipeline."

In times of rising interest rates and wars, pharmacy and medical supplies industries are known to be robust.

"We're comfortable that it's got 8% to 12% earnings growth in the next 2 to 3 years," said Wong.

"We will continue to buy pharmacy products whether the economy is good or bad."

There is also an acquisition that EBOS will settle in the coming 24 months, which will bring it earnings growth, according to Wong.

"The management of this company is really strong."

EBOS, which is dual-listed on the NZX and ASX, has a market capitalisation of $6.9 billion. 

Its ASX shares have lost about 7% for the year so far, closing Friday at $36.05.

According to CMC Markets, 6 out of 10 analysts currently rate the stock as a "buy". Five of them consider it as a "strong buy".

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

3 amazing ASX 200 shares to buy and hold forever

Brokers think these shares are in the buy zone. Let's see why they could be top buy and hold picks.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices.
Broker Notes

Macquarie tips 20% upside for this ASX 200 industrials stock

Let's see what the broker is saying about this stock following an update.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Mum playing with her baby boy holding him on her tummy as she lays down while smiling about the Bubs share price going up today
Broker Notes

Macquarie tips 80% upside for this ASX All Ords healthcare stock

This out of favour stock could be primed for a rebound.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Macquarie tips 40% upside for this ASX 200 real estate stock

Let's see what the broker is saying about this stock.

Read more »

Woman sits at her desk working at night, while traffic flows on a busy freeway out the window behind her.
Broker Notes

Transurban shares: Buy, hold, sell? Here's Macquarie's recommendation

Macquarie’s analysts just ran their slide rules over Transurban shares. Here’s what they found.

Read more »

A woman sits at her home computer with baby on her lap, and the winning ticket in her hand.
Consumer Staples & Discretionary Shares

Which 'enduring high-quality business' has become a forgotten ASX 200 stock?

Fundie says this ASX 200 consumer discretionary stock has been flying under investors' radar.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

Want a financial stock outside the big 4 banks? Macquarie tips 15% upside for this small cap financial

For those searching on the edges, this name could be worth a second look according to Macquarie.

Read more »